Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 1/20 | 0.63 |
| ▸ | CES1 | P23141 | 2/20 | 0.58 |
| ▸ | MAOA | P21397 | 3/20 | 0.47 |
| ▸ | MAOB | P27338 | 3/20 | 0.47 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.47 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.45 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.44 |
| ▸ | PARP1 | P09874 | 1/20 | 0.44 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.44 |
| ▸ | PARP11 | Q9NR21 | 1/20 | 0.44 |
| ▸ | S100A4 | P26447 | 1/20 | 0.43 |
| ▸ | BCHE | P06276 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | PKM | P14618 | 1/20 | 0.40 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.40 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5845169 | 0.77 | ACHE (1.00) | ACHECES1MAOAMAOBCYP2A6 | |
| SCHEMBL13932284 | 0.74 | CES1 (0.46) | ACHECES1MAOAMAOBCYP2A6 | |
| SCHEMBL29408351 | 0.74 | CES1 (0.90) | CES1MAOAMAOBCYP2A6PDPK1 | |
| SCHEMBL13712393 | 0.74 | CES1 (1.00) | CES1MAOAMAOBCYP2A6PDPK1 | |
| SCHEMBL44496 | 0.74 | CES1 (0.90) | CES1MAOAMAOBCYP2A6PDPK1 | |
| SCHEMBL29437756 | 0.74 | CES1 (0.90) | CES1MAOAMAOBCYP2A6PDPK1 | |
| SCHEMBL14450713 | 0.74 | SIGMAR1 (0.41) | ACHECES1MAOAMAOBFOLH1 | |
| SCHEMBL14450714 | 0.72 | SIGMAR1 (0.39) | ACHEMAOAMAOBFOLH1ALDH1A1 | |
| SCHEMBL5258883 | 0.71 | ACHE (0.59) | ACHECES1MAOAMAOBCYP2A6 | |
| SCHEMBL4872563 | 0.71 | CES1 (0.54) | ACHECES1MAOAMAOBCYP2A6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 160 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7893129-B2 | Stable, cationically polymerizable/crosslinkable dental compositions | BLUESTAR SILICONES FRANCE SAS (FR) | 2011-02-22 | — | — | US | claimed |
| US-7893130-B2 | Photocurable dental composition | BLUESTAR SILICONES FRANCE SAS (FR) | 2011-02-22 | — | — | US | claimed |
| EP-1660019-B1 | POLYMERIZABLE DENTAL COMPOSITION HAVING A HIGH CONTENT OF LOADING MATERIAL | BLUESTAR SILICONES FRANCE (FR) | 2010-07-14 | — | — | EP | claimed |
| US-7744772-B2 | Cross-linkable composition for a battery electrolyte | RHODIA CHIMIE (FR) | 2010-06-29 | — | — | US | claimed |
| US-7740482-B2 | Stable cationically crosslinkable/polymerizable dental composition with a high filler content | BLUESTAR SILICONES FRANCE (FR) | 2010-06-22 | — | — | US | claimed |
| EP-1609205-B1 | SETTING COMPOSITION FOR A BATTERY ELECTROLYTE | RHODIA CHIMIE SA (FR) | 2010-04-28 | — | — | EP | claimed |
| EP-1745083-B1 | HIGHLY-CHARGED STABLE DENTAL COMPOSITION WHICH MAY BE CROSS-LINKED/POLYMERISED BY CATIONIC REACTION | BLUESTAR SILICONES FRANCE (FR) | 2009-12-16 | — | — | EP | claimed |
| US-20090258961-A1 | STABLE, CATIONICALLY POLYMERIZABLE/CROSSLINKABLE DENTAL COMPOSITIONS | BLUESTAR SILICONES FRANCE SAS | 2009-10-15 | — | — | US | claimed |
| EP-1744719-B1 | PHOTOPOLYMERISABLE DENTAL COMPOSITION | BLUESTAR SILICONES FRANCE (FR) | 2009-03-25 | — | — | EP | claimed |
| US-20080287562-A1 | Stable cationically crosslinkable/polymerizable dental composition with a high filler content | RHODIA CHIMIE (FR) | 2008-11-20 | — | — | US | claimed |
| EP-0918830-A1 | RELEASE COMPOSITION | RHONE-POULENC INC. (US) | 1999-06-02 | — | — | EP | claimed |
| US-5866261-A | CURABLE EPOXYPOLYSILOXANE | RHODIA INC. (US) | 1999-02-02 | — | — | US | claimed |
| EP-0886667-A1 | INITIATORS FOR THE CATIONIC CROSSLINKING OF POLYMERS CONTAINING ORGANOFUNCTIONAL GROUPS | RHODIA CHIMIE (FR) | 1998-12-30 | — | — | EP | claimed |
| WO-1998028376-A1 | RELEASE COMPOSITION | RHONE-POULENC INC. (US) | 1998-07-02 | — | — | WO | claimed |
| US-5703137-A | POLYORGANOSILOXANES | RHONE-POULENC CHIMIE (FR) | 1997-12-30 | — | — | US | claimed |
| US-5693688-A | AN ONIUM SALT | RHONE-POULENC CHIMIE (FR) | 1997-12-02 | — | — | US | claimed |
| WO-1997033938-A1 | INITIATORS FOR THE CATIONIC CROSSLINKING OF POLYMERS CONTAINING ORGANOFUNCTIONAL GROUPS | RHODIA CHIMIE (US) | 1997-09-18 | — | — | WO | claimed |
| US-5668192-A | POLYMERIZATION CATALYSTS | RHONE-POULENC CHIMIE (FR) | 1997-09-16 | — | — | US | claimed |
| EP-0562922-B1 | Cross-linkable, functional groups containing polysiloxanes and their use for making anti-adhesive coatings | RHONE POULENC CHIMIE (FR) | 1997-05-21 | — | — | EP | claimed |
| US-5340898-A | A mixtures comprising an ionic onium borate photoinitiators; nontoxic | RHONE-POULENC CHIMIE (FR) | 1994-08-23 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080287562-A1 | Stable cationically crosslinkable/polymerizable dental composition with a high filler content | RFC1, RFC2, HNRNPC | ACHE 3449/4885CES1 3775/4885MAOA 1576/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.